Header Logo

Connection

David Bennett to Biomarkers

Back to Details
This is a "connection" page, showing publications David Bennett has written about Biomarkers.
David Bennett
Connection Strength
2.959
Biomarkers
  1. Causes and Patterns of Dementia: An Update in the Era of Redefining Alzheimer's Disease. Annu Rev Public Health. 2019 04 01; 40:65-84.
    View in: PubMed
    Score: 0.514
  2. Alzheimer's disease: Unique markers for diagnosis & new treatment modalities. Indian J Med Res. 2015 Oct; 142(4):369-82.
    View in: PubMed
    Score: 0.409
  3. Galactin-1, 3 and 9: Potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseases. Respir Physiol Neurobiol. 2020 11; 282:103546.
    View in: PubMed
    Score: 0.144
  4. Extending Alzheimer disease biomarker studies into the Hispanic community. Neurology. 2020 10 13; 95(15):665-666.
    View in: PubMed
    Score: 0.144
  5. Antiphospholipid Antibodies: Cognitive and Motor Decline, Neuroimaging and Neuropathology. Neuroepidemiology. 2019; 53(1-2):100-107.
    View in: PubMed
    Score: 0.131
  6. An MRI biomarker of mixed pathology. Neurology. 2018 10 09; 91(15):682-683.
    View in: PubMed
    Score: 0.126
  7. Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol. 2018 12; 136(6):857-872.
    View in: PubMed
    Score: 0.124
  8. Alzheimer disease biomarkers and synucleinopathy. Neurology. 2018 03 20; 90(12):537-538.
    View in: PubMed
    Score: 0.121
  9. Decreased cortical FADD protein is associated with clinical dementia and cognitive decline in an elderly community sample. Mol Neurodegener. 2017 03 20; 12(1):26.
    View in: PubMed
    Score: 0.113
  10. Discovery and Validation of Agonistic Angiotensin Receptor Autoantibodies as Biomarkers of Adverse Outcomes. Circulation. 2017 01 31; 135(5):449-459.
    View in: PubMed
    Score: 0.111
  11. Methylation profiles in peripheral blood CD4+ lymphocytes versus brain: The relation to Alzheimer's disease pathology. Alzheimers Dement. 2016 09; 12(9):942-951.
    View in: PubMed
    Score: 0.106
  12. Plasma biomarkers of depressive symptoms in older adults. Transl Psychiatry. 2012 Jan 03; 2:e65.
    View in: PubMed
    Score: 0.079
  13. Biomarker discovery and analysis platform: application to Alzheimer's disease. Biotechniques. 2005 Oct; 39(4):606-7.
    View in: PubMed
    Score: 0.051
  14. Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults. Acta Neuropathol. 2023 07; 146(1):1-11.
    View in: PubMed
    Score: 0.043
  15. Identification of the A?37/42 peptide ratio in CSF as an improved A? biomarker for Alzheimer's disease. Alzheimers Dement. 2023 01; 19(1):79-96.
    View in: PubMed
    Score: 0.040
  16. Serum metabolomic biomarkers of perceptual speed in cognitively normal and mildly impaired subjects with fasting state stratification. Sci Rep. 2021 09 23; 11(1):18964.
    View in: PubMed
    Score: 0.039
  17. Systemic brain derived neurotrophic factor but not intestinal barrier integrity is associated with cognitive decline and incident Alzheimer's disease. PLoS One. 2021; 16(3):e0240342.
    View in: PubMed
    Score: 0.037
  18. Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med. 2020 05; 26(5):769-780.
    View in: PubMed
    Score: 0.035
  19. Normative Cognitive Decline in Old Age. Ann Neurol. 2020 06; 87(6):816-829.
    View in: PubMed
    Score: 0.035
  20. Sex and APOE e4 genotype modify the Alzheimer's disease serum metabolome. Nat Commun. 2020 03 02; 11(1):1148.
    View in: PubMed
    Score: 0.035
  21. Brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis. Neurobiol Aging. 2020 02; 86:123-133.
    View in: PubMed
    Score: 0.034
  22. Integrating Gene and Protein Expression Reveals Perturbed Functional Networks in Alzheimer's Disease. Cell Rep. 2019 07 23; 28(4):1103-1116.e4.
    View in: PubMed
    Score: 0.033
  23. Candidate-based screening via gene modulation in human neurons and astrocytes implicates FERMT2 in A? and TAU proteostasis. Hum Mol Genet. 2019 03 01; 28(5):718-735.
    View in: PubMed
    Score: 0.032
  24. Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib. Respir Investig. 2019 May; 57(3):290-291.
    View in: PubMed
    Score: 0.032
  25. In vivo hippocampal subfield shape related to TDP-43, amyloid beta, and tau pathologies. Neurobiol Aging. 2019 02; 74:171-181.
    View in: PubMed
    Score: 0.032
  26. Seasonal plasticity of cognition and related biological measures in adults with and without Alzheimer disease: Analysis of multiple cohorts. PLoS Med. 2018 09; 15(9):e1002647.
    View in: PubMed
    Score: 0.031
  27. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018 04; 14(4):535-562.
    View in: PubMed
    Score: 0.030
  28. Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition. Acta Neuropathol. 2018 01; 135(1):85-93.
    View in: PubMed
    Score: 0.030
  29. Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease. J Neuropathol Exp Neurol. 2017 Feb 01; 76(2):70-88.
    View in: PubMed
    Score: 0.028
  30. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology. 2016 Aug 02; 87(5):539-47.
    View in: PubMed
    Score: 0.027
  31. Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease. Alzheimers Dement. 2016 06; 12(6):645-53.
    View in: PubMed
    Score: 0.027
  32. Cerebrovascular and microglial states are not altered by functional neuroinflammatory gene variant. J Cereb Blood Flow Metab. 2016 Apr; 36(4):819-30.
    View in: PubMed
    Score: 0.026
  33. Epigenetic age of the pre-frontal cortex is associated with neuritic plaques, amyloid load, and Alzheimer's disease related cognitive functioning. Aging (Albany NY). 2015 Dec; 7(12):1198-211.
    View in: PubMed
    Score: 0.026
  34. Advances in the prevention of Alzheimer's disease and dementia. J Intern Med. 2014 Mar; 275(3):229-50.
    View in: PubMed
    Score: 0.023
  35. Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological study. Neuroepidemiology. 2013; 40(2):73-84.
    View in: PubMed
    Score: 0.021
  36. Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease. Neurobiol Aging. 2012 Aug; 33(8):1599-608.
    View in: PubMed
    Score: 0.019
  37. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011 May; 7(3):280-92.
    View in: PubMed
    Score: 0.019
  38. Early risk assessment for Alzheimer's disease. Alzheimers Dement. 2009 Mar; 5(2):182-96.
    View in: PubMed
    Score: 0.016
  39. Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis. 2007 Dec; 12(4):377-90.
    View in: PubMed
    Score: 0.015
  40. High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures. Clin Chem. 2005 Oct; 51(10):1946-54.
    View in: PubMed
    Score: 0.013
  41. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol. 1999 Sep 06; 411(4):693-704.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.